Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Now that Washington lawmakers have passed a 45-day stopgap, they have some breathing room to work through some hot-button topics like the high cost of the upcoming Farm Bill, which is due in large part to the funding necessary to support the Nutrition Title.
To mark the end of National Chicken Month, we take a look at how the U.S. poultry industry is making a slow and steady recovery following the widespread outbreak of High-Path Avian Flu (HPAI) in 2022 that devastated commercial flocks across the country.
Calling all FarmHers! RFD-TV’s sister network, FarmHer, just announced a new initiative in the works to empower women in agriculture at a one-day event in Iowa this November.
Seven out of the eight major fertilizers saw recent price decreases. However, one key type of fertilizer bucked the overall trend with an 11-percent rise.
The USDA’s latest crop forecast for corn and soybean production will impact U.S. producers as well as make an impact on global trade.
